检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:兰智霞 孙秀丽 LAN Zhi-xia;SUN Xiu-li(Department of Clinical Medicine,Baotou Clinical Medical College of Inner Mongolia Medical University,Baotou 014040,China)
机构地区:[1]内蒙古医科大学包头临床医学院临床医学系,包头014040
出 处:《中国血液净化》2023年第5期373-376,共4页Chinese Journal of Blood Purification
摘 要:自体动静脉内瘘(arteriovenous fistula,AVF)是血液透析(hemodialysis,HD)患者首选的血管通路,也是终末期肾病(end-stage renal disease,ESRD)患者维持生命的重要渠道。AVF功能障碍增加了ESRD患者住院率及死亡率。目前AVF功能障碍发生机制尚未明确,但其常见原因有血管重塑不足、新生内膜增生(neointimal hyperplasia,NIH)导致的非血栓性血管狭窄。作为Toll样受体(tolllike receptors,TLRs)重要成员的TLR4,在介导血管平滑肌细胞(vascular smooth muscle cells,VSMCs)等细胞的增殖、迁移及细胞外基质(extracellular matrix,ECM)沉积所诱发的NIH致血管狭窄的病理进程中具有关键作用。了解TLR4在AVF狭窄中的确切机制是解决AVF远期通畅问题的当务之急。本文将从AVF狭窄及影响因素、TLR4概述及TLR4/核因子κB(nuclear factor kappa B,NF-κB)信号通路对AVF狭窄的调控作用进行综述。Autologous arteriovenous fistula(AVF)is the preferable vascular access method for hemodi-alysis(HD),being a critical route for end-stage renal disease(ESRD)patients to maintain their lives.AVF dys-function increases the hospitalization rate and mortality of ESRD patients.The mechanism of AVF dysfunc-tion has not been fully elucidated,but insufficient vascular remodeling and neointimal hyperplasia have been considered as the main causes of non-thrombotic vascular stenosis.Toll-like receptor 4(TLR4),an important member in the toll-like receptor family,mediates the proliferation and migration of vascular smooth muscle cells(VSMCs)and deposition of extracellular matrix in AVF wall,leading to intimal hyperplasia and AVF ste-nosis.Comprehension of TLR4 in the development of AVF dysfunction is closely related to the accurate diag-nosis and treatment of AVF dysfunction and maintenance of long-term patency of AVF.Here we summarize the recent progresses in AVF stenosis,its influencing factors,TLR4,and the role of TLR4/NF-κB signal path-way in the pathogenesis of AVF dysfunction.
关 键 词:Toll样受体4/核因子-κB 动静脉内瘘狭窄 炎症 内膜增生 平滑肌细胞
分 类 号:R318.16[医药卫生—生物医学工程]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222